173 related articles for article (PubMed ID: 30604502)
1. USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer.
Ouyang SW; Liu TT; Liu XS; Zhu FX; Zhu FM; Liu XN; Peng ZH
FEBS Lett; 2019 Feb; 593(4):406-413. PubMed ID: 30604502
[TBL] [Abstract][Full Text] [Related]
2. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN.
Sun J; Li T; Zhao Y; Huang L; Sun H; Wu H; Jiang X
Mol Cell Biochem; 2018 Apr; 441(1-2):1-7. PubMed ID: 28852924
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity.
Han Y; Yun CC
FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitination and stabilization of T-bet by USP10.
Pan L; Chen Z; Wang L; Chen C; Li D; Wan H; Li B; Shi G
Biochem Biophys Res Commun; 2014 Jul; 449(3):289-94. PubMed ID: 24845384
[TBL] [Abstract][Full Text] [Related]
5. USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation.
Lin Z; Yang H; Tan C; Li J; Liu Z; Quan Q; Kong S; Ye J; Gao B; Fang D
Cell Rep; 2013 Dec; 5(6):1639-49. PubMed ID: 24332849
[TBL] [Abstract][Full Text] [Related]
6. USP10 regulates p53 localization and stability by deubiquitinating p53.
Yuan J; Luo K; Zhang L; Cheville JC; Lou Z
Cell; 2010 Feb; 140(3):384-96. PubMed ID: 20096447
[TBL] [Abstract][Full Text] [Related]
7. USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein.
Yang JR; Lu YB; Su HX; Xiao Y; Pan Q; Su F; Zhang XB; Zhu KL; Guan QL; Ling XL
Biochem Pharmacol; 2023 Dec; 218():115864. PubMed ID: 37863330
[TBL] [Abstract][Full Text] [Related]
8. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF.
Ko A; Han SY; Choi CH; Cho H; Lee MS; Kim SY; Song JS; Hong KM; Lee HW; Hewitt SM; Chung JY; Song J
Cell Death Differ; 2018 Jun; 25(6):1050-1062. PubMed ID: 29472714
[TBL] [Abstract][Full Text] [Related]
9. USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.
Lu C; Ning Z; Wang A; Chen D; Liu X; Xia T; Tekcham DS; Wang W; Li T; Liu X; Liu J; Qi H; Luo H; Du J; Ma C; Yan Q; Liu J; Xu G; Piao HL; Tan G
Cancer Lett; 2018 Nov; 436():139-148. PubMed ID: 30056112
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
[TBL] [Abstract][Full Text] [Related]
13. Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer.
Takayama KI; Suzuki T; Fujimura T; Takahashi S; Inoue S
Mol Cancer Res; 2018 May; 16(5):846-856. PubMed ID: 29378906
[TBL] [Abstract][Full Text] [Related]
14. USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.
Ouchida AT; Kacal M; Zheng A; Ambroise G; Zhang B; Norberg E; Vakifahmetoglu-Norberg H
Biochem Biophys Res Commun; 2018 Aug; 502(4):429-434. PubMed ID: 29803676
[TBL] [Abstract][Full Text] [Related]
15. USP10 Regulates ZEB1 Ubiquitination and Protein Stability to Inhibit ZEB1-Mediated Colorectal Cancer Metastasis.
Sun L; Yu J; Guinney J; Qin B; Sinicrope FA
Mol Cancer Res; 2023 Jun; 21(6):578-590. PubMed ID: 36940483
[TBL] [Abstract][Full Text] [Related]
16. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer.
Quan G; Xu J; Wang J; Liu X; Xu J; Jiang J
Cell Death Dis; 2023 Feb; 14(2):137. PubMed ID: 36807568
[TBL] [Abstract][Full Text] [Related]
17. The stability and oncogenic function of LIN28A are regulated by USP28.
Haq S; Das S; Kim DH; Chandrasekaran AP; Hong SH; Kim KS; Ramakrishna S
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):599-610. PubMed ID: 30543854
[TBL] [Abstract][Full Text] [Related]
18. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis.
Wang X; Xia S; Li H; Wang X; Li C; Chao Y; Zhang L; Han C
Cell Death Differ; 2020 Jun; 27(6):1747-1764. PubMed ID: 31748695
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis.
Sun T; Xu YJ; Jiang SY; Xu Z; Cao BY; Sethi G; Zeng YY; Kong Y; Mao XL
Acta Pharmacol Sin; 2021 Aug; 42(8):1338-1346. PubMed ID: 33184448
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin isopeptidase USP10 deubiquitinates LC3B to increase LC3B levels and autophagic activity.
Jia R; Bonifacino JS
J Biol Chem; 2021; 296():100405. PubMed ID: 33577797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
